Palvella Therapeutics Completes $45 Million Series C Financing
Investor Syndicate Comprised of Leading Biotech Investors  

Proceeds to Accelerate  Pipeline of Rare Disease Therapies, Including Late-Stage Programs in Pachyonychia Congenita and Gorlin Syndrome  

Top-Line Data Expected in Q4 2020 from Phase 2/3 Pivotal Study for Fast Track-Designated Lead Program Pachyonychia Congenita    

See more here


Annovis Bio Files Patent Application for Method of Inhibiting, Preventing, or Treating Neurological Injuries Due to Viral and Other Infections Including COVID-19

See more here


Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder

Phase 3 Program Can Advance and the Company Plans to Initiate Registration Studies in the Fourth Quarter of 2020 

See more here


Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations

See more here


Ride Health Launches First Comprehensive COVID-19 Equipped Transportation Network for New York City Metropolitan Area 

See more here


Keriton Kare Selected by Connecticut Children’s to Improve Quality and Safety of Feeding Management in Its NICU and PICU
While the Keriton Kare Mom app is designed to help mothers produce more breast milk, its chat and photo-sharing functions have proven to be a lifeline during the pandemic — allowing separated parents to stay engaged in the care and development of their children.

See more here


Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients

See more here


Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options
Serious bacterial infections among major causes of disability and death for people in healthcare settings.  

Collaboration comes at critical time with studies showing bacterial infections present in half of deceased COVID-19 patients.   

See more here


Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs

See more here


Wellsheet Used by Physicians at Concord Hospital Battling COVID-19 Outbreak
Predictive Workflow Platform Provides Coronavirus Alerts, Clinical Visibility, and Reduces Time in the EHR and Reduces Physician Burnout  

See more here